SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Merrimack Pharmaceuticals Yesterday Reported Q1 EPS $0.020 Up From $(0.780) YoY

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly earnings of $0.020 per share. This is a 102.56 percent increase over losses of $(0.780) per share from the same period last year.

Benzinga · 05/08/2020 14:48

Merrimack Pharmaceuticals (NASDAQ:MACK) reported quarterly earnings of $0.020 per share. This is a 102.56 percent increase over losses of $(0.780) per share from the same period last year.